Inovio Pharmaceuticals (INO) Surges on Heavy Volume

NEW YORK (TheStreet) -- Inovio Pharmaceuticals (INO) closed Thursday higher on heavier-than-normal trading volume.

The micro-cap biotechnology company booked 12.7% gains over the session to close at $3.64 a share. Inovio's share price is still 36 cents shy of its 52-week high of $3.95. Year to date, the stock is up 25.5%.

Trading volume of 17 million shares exceeded its three-month daily average of 10.3 million shares.

Must Read: Warren Buffett's 10 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

INO Chart INO data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Sage Skyrockets on Postpartum Depression Drug Studies Data -- Biotech Movers

Sage Skyrockets on Postpartum Depression Drug Studies Data -- Biotech Movers

Inovio Rises On Phase 1 Data for Zika Vaccine -- Biotech Movers

Inovio Rises On Phase 1 Data for Zika Vaccine -- Biotech Movers

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)

Chevron, Universal Display, Dynavax Technologies, Schlumberger: 'Mad Money' Lightning Round

Chevron, Universal Display, Dynavax Technologies, Schlumberger: 'Mad Money' Lightning Round